1265885-65-1

Basic information

• Product Name: 6-{2-[2-(4-chloro-2-methyl-phenyl)-5,6-difluoro-benzoimidazol-1-yl]-2-cyclohexyl-ethoxy}-nicotinic acid methyl ester
• Synonyms: 6-{2-[2-(4-chloro-2-methyl-phenyl)-5,6-difluoro-benzoimidazol-1-yl]-2-cyclohexyl-ethoxy}-nicotinic acid methyl ester
• CAS NO: 1265885-65-1
• Molecular Weight: 540.009
• Mol File: 1265885-65-1.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 6-{2-[2-(4-chloro-2-methyl-phenyl)-5,6-difluoro-benzoimidazol-1-yl]-2-cyclohexyl-ethoxy}-nicotinic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 6-{2-[2-(4-chloro-2-methyl-phenyl)-5,6-difluoro-benzoimidazol-1-yl]-2-cyclohexyl-ethoxy}-nicotinic acid methyl ester(1265885-65-1)
• EPA Substance Registry System: 6-{2-[2-(4-chloro-2-methyl-phenyl)-5,6-difluoro-benzoimidazol-1-yl]-2-cyclohexyl-ethoxy}-nicotinic acid methyl ester(1265885-65-1)

Safety Data

• Hazardous Substances Data: 1265885-65-1(Hazardous Substances Data)

Upstream product

• 66171-50-4 methyl 6-hydroxynicotinate 
• 1265885-64-0 2-[2-(4-chloro-2-methyl-phenyl)-5,6-difluoro-benzoimidazol-1-yl]-2-cyclohexyl-ethanol 

Relevant articles and documents

NEW BENZIMIDAZOLE DERIVATIVES

The invention is concerned with novel benzimidazole derivatives of Formula (I) wherein A, n and R1 to R7 are as defined in the description and in the claims, as well as physiologically acceptable salts and esters thereof. These compounds act on Farnesyl X receptor (FXR) and against cholesterol and lipid illnesses, diabetes, obesity, psoriasis, cancer, osteoporosis, Parkinson's and Alzheimer's disease.